stoxline Quote Chart Rank Option Currency Glossary
  
NanoString Technologies, Inc. (NSTG)
0.1053  -0.063 (-37.43%)    05-13 16:00
Open: 0.128
High: 0.13999
Volume: 21,428,464
  
Pre. Close: 0.1683
Low: 0.1025
Market Cap: 5(M)
Technical analysis
2024-05-17 4:47:29 PM
Short term     
Mid term     
Targets 6-month :  0.32 1-year :  0.46
Resists First :  0.27 Second :  0.4
Pivot price 0.21
Supports First :  0.07 Second :  0.05
MAs MA(5) :  0.15 MA(20) :  0.18
MA(100) :  0.27 MA(250) :  1.94
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  20.7 D(3) :  28.4
RSI RSI(14): 40.6
52-week High :  8.88 Low :  0.03
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ NSTG ] has closed above bottom band by 13.9%. Bollinger Bands are 8.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.14 - 0.14 0.14 - 0.14
Low: 0.1 - 0.1 0.1 - 0.1
Close: 0.1 - 0.11 0.11 - 0.11
Company Description

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.

Headline News

Wed, 15 May 2024
NanoString Technologies, Inc. Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Movies Canada

Fri, 03 May 2024
Wall Street Analysts See a 172% Upside in NanoString (NSTG): Can the Stock Really Move This High? - Yahoo New Zealand News

Tue, 13 Feb 2024
NanoString Tech Initiates Chapter 11 Proceedings with Asset Sale Plans - TipRanks.com - TipRanks

Fri, 09 Feb 2024
NanoString Announces Completion of Financing to Support Restructuring Process - Business Wire

Fri, 09 Feb 2024
NanoString secures $47.5 million to support restructuring By Investing.com - Investing.com

Thu, 08 Feb 2024
NanoString stock to end Nasdaq trading (NASDAQ:NSTG) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 0 (M)
Shares Float 48 (M)
Held by Insiders 3.941e+007 (%)
Held by Institutions 3.1 (%)
Shares Short 5,350 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.4849e+008
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin -102.5 %
Operating Margin -75.9 %
Return on Assets (ttm) -30.9 %
Return on Equity (ttm) -1 %
Qtrly Rev. Growth 1.6247e+008 %
Gross Profit (p.s.) 50.64
Sales Per Share 23.03
EBITDA (p.s.) 0
Qtrly Earnings Growth -3.6 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -115 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -0.13
Stock Dividends
Dividend 0
Forward Dividend 6.04e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android